According to research findings, when TRPM2-mediated calcium influx is inhibited, the mitochondria are dysfunctional, cellular bioenergetics is reduced, and the production of ROS is increased, thereby decreasing tumor growth and increasing chemotherapy sensitivity (Miller, 2019). This evidence concerns the gene TRPM2 and neoplasm.